Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    GALE

Delayed Quote. Delayed  - 08/24 07:45:43 pm
0.4401 USD   -2.13%
08/23 STOCKS IN SPOTL : Galena Biopharma, Inc. Amsurg Corp.
08/09 GALENA BIOPHARM : beats 2Q profit forecasts
08/09 Galena Biopharma Reports Second Quarter 2016 Financial Results an..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/18/2016 08/19/2016 08/22/2016 08/23/2016 08/24/2016 Date
0.403(c) 0.4304(c) 0.4361(c) 0.4497(c) 0.4401 Last
2 076 155 6 748 003 2 728 756 4 675 098 1 705 677 Volume
+0.37% +6.80% +1.32% +3.12% -2.13% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -34,7 M
Net income 2016 -24,3 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -31,9 M
Net income 2017 -29,8 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 96,2 M
More Financials
Company
Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of... 
Sector
Pharmaceuticals
Calendar
11/07Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating : -
More Ratings
Latest news on GALENA BIOPHARMA INC
08/23 STOCKS IN SPOTLIGHT : Galena Biopharma, Inc. Amsurg Corp.
08/23 GALENA BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Material Mo..
08/22 GALENA BIOPHARMA, INC. : Financial Statements and Exhibits (form 8-K)
08/16 GALENA BIOPHARMA, INC. : Notice of Delisting or Failure to Satisfy a Continued L..
08/12 GALENA BIOPHARMA, INC. : Entry into a Material Definitive Agreement (form 8-K)
08/09 GALENA BIOPHARMA : beats 2Q profit forecasts
08/09 GALENA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
08/09 GALENA BIOPHARMA, INC. : Results of Operations and Financial Condition, Change i..
08/09 Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a..
07/26 Galena Biopharma to Report Second Quarter 2016 Financial Results and Provide ..
More news
Sector news : Pharmaceuticals - NEC
11:34aDJPFIZER : Buys Part of AstraZeneca's Antibiotics Business -- 2nd Update
10:32aDJASTRAZENECA : Sells Part of its Antibiotics Business to Pfizer -- Update
10:15aDJPfizer Buys Part of AstraZeneca's Antibiotics Business
09:48a ASTRAZENECA : Pfizer to buy antibiotics business from AstraZeneca
09:03aDJASTRAZENECA : Sells Part of Antibiotics Business to Pfizer for Up to $1.575 Bill..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01:59a Best And Worst Performing Stocks Of 2016
08/09 Galena Biopharma's (GALE) CEO Mark Schwartz on Q2 2016 Results - Earnings Cal..
08/09 Galena Biopharma beats by $0.09
08/08 Notable earnings after Tuesday?s close
07/12 Galena issues over 3.6M shares of stock to resolve outstanding issues
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 1,13 $
Spread / Average Target 152%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark W. Schwartz President, Chief Executive Officer & Director
Sanford J. Hillsberg Chairman
Gavin S. Choy Senior VP-Clinical Sciences & Operations
Bijan Nejadnik Chief Medical Officer & Executive Vice President
Stephen S. Galliker Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC-69.41%96
JOHNSON & JOHNSON16.28%326 773
ROCHE HOLDING LTD.-12.26%219 257
NOVARTIS AG-9.97%214 603
PFIZER INC.8.71%212 844
MERCK & CO., INC.20.37%175 812
More Results